Department of Surgery, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.
Am J Transplant. 2011 Jun;11(6):1296-301. doi: 10.1111/j.1600-6143.2011.03484.x. Epub 2011 Mar 30.
CD4⁺ Tregs specific for noninherited maternal antigens (NIMA(d) ) are detectable in some but not all B6 × BDF₁ backcross, H-2(b) homozygous offspring, and their presence is strongly correlated with extent of maternal (BDF₁) microchimerism. We hypothesized that the level of pretransplant donor antigen-specific Tregs could predict allograft tolerance. To test this idea, mice were screened for bystander suppression in a DTH assay, followed 1 week later by DBA/2 heterotopic heart transplantation. NIMA(d) -exposed, H-2(b) offspring that failed to suppress DTH uniformly rejected heart allografts (12/12) by d15. In contrast, 5/6 NIMA(d) -exposed DTH 'regulators' accepted their allografts >100 days. The defect in 'nonregulator" offspring could be corrected by transfer of CD4⁺CD25⁺, but not CD4⁺ CD25(neg) or CD8⁺ T cells from transplant acceptor mice. In conclusion, donor-specific T reg screening of F1 backcross offspring correctly predicted which recipients would accept a heart allograft. If translated to the clinic, similar pretransplant Treg screening could greatly enhance the effectiveness of tolerance as a clinical strategy in transplantation between family members.
在一些但不是所有 B6 × BDF₁回交、H-2(b)纯合子后代中可检测到针对非遗传母体抗原 (NIMA(d)) 的 CD4⁺ Tregs,并且它们的存在与母体 (BDF₁) 微嵌合体的程度强烈相关。我们假设移植前供体抗原特异性 Tregs 的水平可以预测同种异体移植物的耐受性。为了验证这一想法,我们通过迟发型超敏反应 (DTH) 测定对小鼠进行了旁观者抑制筛选,1 周后进行 DBA/2 异位心脏移植。未能抑制 DTH 的 NIMA(d) 暴露、H-2(b) 后代均在 d15 时均匀排斥心脏同种异体移植物 (12/12)。相比之下,5/6 的 NIMA(d) 暴露 DTH“调节剂”接受了他们的同种异体移植物 >100 天。“非调节剂”后代的缺陷可以通过从移植接受者小鼠中转移 CD4⁺CD25⁺,但不是 CD4⁺ CD25(neg) 或 CD8⁺ T 细胞来纠正。总之,F1 回交后代的供体特异性 Treg 筛选正确预测了哪些受者将接受心脏同种异体移植物。如果将其转化为临床实践,类似的移植前 Treg 筛选可以极大地提高作为亲属间移植中临床策略的耐受性的有效性。